Literature DB >> 3623715

Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells.

A B Griffiths, J Burchell, S Gendler, A Lewis, K Blight, R Tilly, J Taylor-Papadimitriou.   

Abstract

Many existing MAbs raised against the human milk fat globule or against carcinoma cells recognise epitopes on high-molecular-weight glycoproteins. In a comparative ELISA assay a number of these antibodies have been shown to react with an extract of the human milk fat globule. In comparative immunoblots of cultured normal milk cells and breast cell lines, all were found to bind to large molecules which show some variation in molecular weight depending on the cell source. The HMFG-2 antibody, which is widely used in cancer diagnosis, also recognises epitopes on lower-molecular-weight components. In T47D cells these may be as small as 80,000 Mr, and with electron microscopy this cell line can be shown to accumulate HMFG-2-reactive components in the Golgi apparatus. Using an HMFG-2 affinity column we have immunopurified HMFG-2-reactive material from the 2 breast cancer cell lines MCF-7 and T47D and shown that all of the above antibodies react in a solid-phase ELISA with the purified material. In addition to high-molecular-weight components, the immunopurified material was found to contain lower-molecular-weight components including a glycoprotein of 68,000 Mr that was not, however, recognised by the HMFG-2 antibody on a Western blot. We have used this immunopurified material to generate new MAbs. All of these recognise the high-molecular-weight bands seen with the other antibodies, but 2 of them also recognise a band at 68,000 Mr in blots of MCF-7 and T47D. The second-generation antibodies show a spectrum of reactivity on tissues similar to HMFG-2 and one reacts at least as strongly as HMFG-2 with methanol-acetone-fixed sections of breast cancers.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3623715     DOI: 10.1002/ijc.2910400307

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  MUC1 mucin and carbohydrate associated antigens as tumor markers in head and neck squamous cell carcinoma.

Authors:  M V Croce; M E Rabassa; M R Price; A Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  Analysis of the tumour-associated antigen TAG-12 by monoclonal antibody 7A9 in normal, benign and malignant mammary tissues.

Authors:  M Werner; R von Wasielewski; J Bernhards; A Georgii
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 3.  Gene-based vaccines and immunotherapeutics.

Authors:  Margaret Liu; Bruce Acres; Jean-Marc Balloul; Nadine Bizouarne; Stephane Paul; Philippe Slos; Patrick Squiban
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-27       Impact factor: 11.205

4.  Secretory component in differentiating normal epithelium, benign lesions and malignancy in the human breast as monitored by monoclonal antibodies.

Authors:  J Bártek; H Tlaskalová-Hogenová; Z Stasková; J Simecková; B Vojtĕsek; A Rejthar; J Kovarík; J Bartková
Journal:  Histochemistry       Date:  1989

5.  Epithelial membrane antigen expression in breast fluids and 'witch's milk'.

Authors:  C J Williams; A S Dion; J Carten; G C Buehring
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

6.  Assessment of milk fat globule membrane antibodies and lectins as markers of short-term prognosis in breast cancer.

Authors:  R A Walker
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

7.  Polymorphic epithelial mucin from the sera of advanced breast cancer patients--isolation and partial characterisation.

Authors:  C O'Sullivan; M R Price; R W Baldwin
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

8.  Antigenic modulation of metastatic breast and ovary carcinoma cells by intracavitary injection of IFN-alpha.

Authors:  P Giacomini; M Mottolese; R Fraioli; M Benevolo; I Venturo; P G Natali
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

9.  The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125.

Authors:  J Fisken; J E Roulston; C Sturgeon; R A Badley; I Jönrup; L Aspinall; R C Leonard
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

10.  Aberrant expression of intestinal mucin antigens associated with colorectal carcinoma defined by a panel of monoclonal antibodies.

Authors:  P J Hertzog; S J Pilbrow; J Pedersen; A L Polglase; M Lawson; A W Linnane
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.